Insmed
INSM
#625
Rank
A$56.37 B
Marketcap
A$264.34
Share price
4.98%
Change (1 day)
137.42%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -A$1.71 Billion

According to Insmed's latest financial reports the company's current earnings are A$0.44 Billion. In 2024 the company made an earning of -A$1.26 Billion a decrease over its 2023 earnings that were of -A$1.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$1.71 Billion36.23%
2024 -A$1.26 Billion23.71%
2023 -A$1.02 Billion45.77%
2022 -A$0.7 Billion15.83%
2021 -A$0.61 Billion50.19%
2020 -A$0.4 Billion16.4%
2019 -A$0.35 Billion-23.9%
2018 -A$0.46 Billion59.35%
2017 -A$0.29 Billion8.52%
2016 -A$0.27 Billion47.25%
2015 -A$0.18 Billion34.53%
2014 -A$0.14 Billion58.83%
2013 -A$82.98 Million35.14%
2012 -A$61.4 Million-31.92%
2011 -A$90.2 Million854.92%
2010 -A$9.45 Million-105.22%
2009 A$0.18 B-905.06%
2008 -A$22.47 Million-27.31%
2007 -A$30.91 Million-62.41%
2006 -A$82.21 Million98.19%
2005 -A$41.48 Million0.03%
2004 -A$41.47 Million159.07%
2003 -A$16.01 Million-69.31%
2002 -A$52.15 Million
2000 -A$47.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-A$0.39 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.82 B-1,591.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A$14.94 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$6.66 M-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$35.14 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.74 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA